Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection-Reference-Cited by-同舟云学术

Clinical significance of the Lacdi NA c‐glycosylated prostate‐specific antigen assay for prostate cancer detection

Published:2019-06-27 Issue:8 Volume:110 Page:2573-2589
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Yoneyama Tohru¹²^ORCID,Tobisawa Yuki²,Kaneko Tomonori³,Kaya Takatoshi³,Hatakeyama Shingo²^ORCID,Mori Kazuyuki²,Sutoh Yoneyama Mihoko⁴,Okubo Teppei⁵,Mitsuzuka Koji⁵,Duivenvoorden Wilhelmina⁶,Pinthus Jehonathan H.⁶,Hashimoto Yasuhiro²,Ito Akihiro⁵,Koie Takuya⁷,Suda Yoshihiko³,Gardiner Robert A.⁸⁹,Ohyama Chikara¹²

Affiliation:

1. Department of Advanced Transplant and Regenerative Medicine Hirosaki University Graduate School of Medicine Hirosaki Japan

2. Department of Urology Hirosaki University Graduate School of Medicine Hirosaki Japan

3. Corporate R&D Headquarters Konica Minolta Tokyo Japan

4. Department of Cancer Immunology and Cell Biology Oyokyo Kidney Research Institute Hirosaki Japan

5. Department of Urology Tohoku University Graduate School of Medicine Sendai Japan

6. Department of Surgery McMaster University Hamilton Ontario Canada

7. Department of Urology Gifu University Graduate School of Medicine Gifu Japan

8. Department of Urology Royal Brisbane and Women's Hospital Brisbane Australia

9. Faculty of Medicine The University of Queensland Herston Queensland Australia

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14082

Reference36 articles.

1. When is Prostate Cancer Really Cancer?

2. Active surveillance versus radical treatment for favorable-risk localized prostate cancer

3. Prostate cancer overdiagnosis and overtreatment

4. Prostate-specific antigen-based screening: controversy and guidelines

5. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary miRNAs and Prostate Cancer: Is there a Crossover Point Eventually, and where should we Head?;Current Medicinal Chemistry;2024-12

2. Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer;Advanced Science;2024-06-17

3. Synthesis and unexpected binding of monofluorinated N,Nʹ-diacetylchitobiose and LacdiNAc to wheat germ agglutinin;Bioorganic Chemistry;2024-06

4. Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity;Clinica Chimica Acta;2024-06

5. Increased α2,3‐sialyl N‐glycosylated prostate‐specific membrane antigen (PSMA) in post‐DRE urine is associated with high grade group prostate cancer;The Prostate;2024-05-12